About Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. is developing novel therapies that can be precisely controlled after delivery, for enhanced efficacy and ultimate safety. BPX-201 is an autologous vaccine in clinical development for patients with prostate cancer, and BPX-501 is in clinical development for patients undergoing hematopoietic stem cell transplantation. Specialties Oncology, Vaccines, Cell Therapy, Bone Marrow Transplantation
Bellicum Pharmaceuticals, Inc. Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location
X